BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23307189)

  • 21. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
    Xiao GQ; Burstein DE; Miller LK; Unger PD
    Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clear cell adenocarcinoma of the male urethra.
    Gögus C; Baltaci S; Orhan D; Yaman O
    Int J Urol; 2003 Jun; 10(6):348-9. PubMed ID: 12757608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
    Turcan D; Acikalin MF; Yilmaz E; Canaz F; Arik D
    Pathol Res Pract; 2017 Jul; 213(7):831-835. PubMed ID: 28554748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colon adenoma and adenocarcinoma with clear cell components - two case reports.
    Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Okamoto K; Wada J; Urabe S; Daa T
    Diagn Pathol; 2019 May; 14(1):37. PubMed ID: 31077226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell adenocarcinoma of the male urethra in association with so-called nephrogenic metaplasia.
    Seseke F; Zöller G; Kunze E
    Urol Int; 2001; 67(1):104-8. PubMed ID: 11464132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
    Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
    Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
    Jassim SH; Khiyami A; Nguyen JK; Ganesan S; Tomashefski J; Sawady J
    J Med Case Rep; 2017 May; 11(1):133. PubMed ID: 28494807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female urethral adenocarcinoma: evidence for more than one tissue of origin?
    Dodson MK; Cliby WA; Pettavel PP; Keeney GL; Podratz KC
    Gynecol Oncol; 1995 Dec; 59(3):352-7. PubMed ID: 8522254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell adenocarcinoma of the urethra with inguinal lymph node metastases: A rare case report and review of literature.
    Mallya V; Mallya A; Gayathri J
    J Cancer Res Ther; 2018; 14(2):468-470. PubMed ID: 29516944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesical clear cell adenocarcinoma. V. Nephrogenic adenoma: a diagnostic problem.
    Alsanjari N; Lynch MJ; Fisher C; Parkinson MC
    Histopathology; 1995 Jul; 27(1):43-9. PubMed ID: 7557905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell adenocarcinoma of the female urethra: magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(1):142-4. PubMed ID: 19188802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
    Alshenawy HA
    Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clear cell adenocarcinoma of the urinary bladder: a short review.
    Adeniran AJ; Tamboli P
    Arch Pathol Lab Med; 2009 Jun; 133(6):987-91. PubMed ID: 19492895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.
    Vang R; Whitaker BP; Farhood AI; Silva EG; Ro JY; Deavers MT
    Int J Gynecol Pathol; 2001 Jul; 20(3):252-9. PubMed ID: 11444201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic Adenoma of Female Urethra.
    Puertas C; Fernández S; Llaneza P
    J Low Genit Tract Dis; 2016 Jul; 20(3):e50-1. PubMed ID: 27172117
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and pathologic features of tubulocystic carcinoma of kidney].
    Zhang SH; Shi SF; Huang SF; Zhang YN; Zheng YY; Chen GY
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):543-6. PubMed ID: 23157747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary clear-cell adenocarcinoma of the proximal female urethra: case report and review of the literature.
    Miller J; Karnes RJ
    Clin Genitourin Cancer; 2008 Sep; 6(2):131-3. PubMed ID: 18824439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.